Showing results (351-360 of 396) with videos related to
Sort By:
Pageof 40
The European Respiratory Journal|August 12, 2017
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patientsMyriam Delaunay, Jacques Cadranel, Amélie Lusque, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 15, 2025
Surgical Results after Neoadjuvant Nivolumab and Platinum-based Chemotherapy for Resectable Lung Cancer. A Multicentre European Real Clinical Practice AnalysisAlessandro Brunelli, Alessio Mariolo, Clemens Aigner, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2023
The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: A Re-Assessment of the International Thymic Malignancy Interest Group/International Association for the Study of Lung Cancer Lymph Node Map for Thymic Epithelial Tumors for the Forthcoming Ninth Edition of the TNM Classification of Malignant TumorsEdith M Marom, Wentao Fang, Enrico Ruffini, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2023
The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposal for a Stage Classification for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant TumorsEnrico Ruffini, James Huang, Vanessa Cilento, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2024
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 StudyMyung-Ju Ahn, Kentaro Tanaka, Luis Paz-Ares, et al.Kidney International Reports|February 23, 2026
Immune Profiling Identifies High-Risk Neutrophil-Rich Subtype in Checkpoint Inhibitor NephritisIdris Boudhabhay, Helene Lazareth, Julie Oniszczuk, et al.The New England Journal of Medicine|October 17, 2025
Sevabertinib in Advanced <i>HER2</i>-Mutant Non-Small-Cell Lung CancerXiuning Le, Tae Min Kim, Herbert H Loong, et al.The New England Journal of Medicine|June 2, 2025
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung CancerPatrick M Forde, Jonathan D Spicer, Mariano Provencio, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 29, 2023
The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposals for the N and the M Components for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant TumorsWentao Fang, Nicolas Girard, Vanessa Cilento, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2026
Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II TrialThomas Pierre Walter, Julien Mazieres, Josiane Otto, et al.Pageof 40